Cargando…
MicroRNA-30 inhibits the growth of human ovarian cancer cells by suppressing RAB32 expression
INTRODUCTION: MicroRNAs (miRs) exhibit the potential to act as therapeutic targets for the management of human cancers including ovarian cancer. The role of microRNA-30 (miR-30) via modulation of RAB32 expression has not been studied in ovarian cancer. Consistently, the present study was designed to...
Autores principales: | Zhang, Yan, Zhou, Min, Li, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744078/ https://www.ncbi.nlm.nih.gov/pubmed/34986662 http://dx.doi.org/10.1177/20587384211058642 |
Ejemplares similares
-
microRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18
por: Zhong, Keng, et al.
Publicado: (2014) -
MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression
por: Jiashi, Wang, et al.
Publicado: (2018) -
MicroRNA-599 suppresses glioma progression by targeting RAB27B
por: Jiang, Yu, et al.
Publicado: (2021) -
MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis
por: Shi, Min, et al.
Publicado: (2018) -
Magic and mystery of microRNA‐32
por: Zeng, ZL, et al.
Publicado: (2021)